Vnitr Lek 2020, 66(8):472-477 | DOI: 10.36290/vnl.2020.142

Bariatry - surgical therapy of the severe obesity

Mojmír Kasalický1,2
1 Chirurgická klinika 2. LF UK a ÚVN, Praha
2 Fakulta zdravotníctva a sociálnej práce, Trnavská univerzita

When conservative therapy of the morbid obesity repeatedly fails bariatric surgery begins. Adults patients from 18 to 60 age with obesity 3rd grade (BMI > 40 kg/m2), respectively 2nd grade (BMI > 35 kg/m2), with symptomatic diseases caused by obesity as type 2 diabetes, hypertension, dyslipidaemia or heavy failure of the joints, in which conservative therapy failed, are indicate for bariatric surgery. Nearly all of the bariatric procedures are providing by laparoscopy at present. Contemporary bariatric surgery is using restrictive or malabsorptive or combination of both operating methods. Adjustable gastric banding and vertical gastric plication are pure restrictive bariatric method. The most popular restrictive method with partial hormonal effect is sleeve gastrectomy at present. Biliopancreatic diversion is considered to be a pure malabsorptive bariatric method. Majority of the bariatric surgeons consider gastric bypasses as malabsorptive restrictive method.

Keywords: bariatric methods, diabetes, obesity.

Published: December 15, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kasalický M. Bariatry - surgical therapy of the severe obesity. Vnitr Lek. 2020;66(8):472-477. doi: 10.36290/vnl.2020.142.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Angrisani L, et al. (2015). Bariatric Surgery Worldwide 2014. Obes Surg, 25(10): 1822-1832. Go to original source... Go to PubMed...
    2. Navarrete SA, Leyba JL, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypasses for the treatment of type 2 diabetes in non‑obese patiens: technice and prelimitary results. Obes Surg 2011; 5: 663-667. Go to original source... Go to PubMed...
    3. Kasalický, M. Bariatrie, chirurgická léčba obezity a cukrovky, 2018, Maxdorf Praha, ISBN 978-80-7345-593-4.
    4. Buchwald H, Estok R, Fahrbach K, et al. (2019). Weight and type 2 diabetes after bariatric surgery: systematic review and meta‑analysis. Am J Med,122: 248-256. Go to original source... Go to PubMed...
    5. Buchwald H, et al. Metabolic Surgery. New York, Grune a Stratton, 1978.
    6. Kasalicky M. (2012). Pohled na současnou bariatricko‑metabolickou chirurgii. Rozhl Chir, 91(1): 5-11. Go to PubMed...
    7. Di Lorenzo N, Antoniou SA, Batterham RL, el al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO‑EC, EASO and ESPCOP. Surg Endosc 2020, DOI 10.1007/s00464-020-07555-y. ISSN 0930-2794. Go to original source... Go to PubMed...
    8. Fried M, Gryga A, Herlesova J, et al. Obecné indikace a kontraindikace k bariatrii. Rozhl Chir 2013; 92: 41-44. Go to original source...
    9. Benedix F, Westphal S, Patschke E, et al. Weight Loss and Changes in Salivary Ghrelin and Adiponectin: Comparison Between Sleeve Gastrectomy and Roux‑en‑Y Gastric Bypass and Gastric Banding. Obes Surg, 2011; 21: 616-624. Go to original source... Go to PubMed...
    10. Ramos A, Neto MG, Galvao M, et al. Laparoscopic great curvature placation: Initial results of an alternative restrictive bariatric procedure. Obes Surg 2010; 20: 913-918. Go to original source... Go to PubMed...
    11. Gagner M, Hutchinson C, Rosenthal R. (2016). Fifth International Consensus Conference: current status of sleeve gastrectomy. Surg Obes Relat Dis, 12: 750-756. Go to original source... Go to PubMed...
    12. Scopinaro N, Adami FG, Papadia FS, et al. The effects of biliopancreatic diversion on type 2 diabetes mellitus in patients with mild obesity (BMI 30-35 kg/m2) and simple overweight (BMI 25-30 kg/m2): A prospective controlled study. Obes Surg 2011; 21: 880-888. Go to original source... Go to PubMed...
    13. Benedix F, Westphal S, Patschke E, et al. Weight Loss and Changes in Salivary Ghrelin and Adiponectin: Comparison Between Sleeve Gastrectomy and Roux‑en‑Y Gastric Bypass and Gastric Banding. Obes Surg, 2011; 21: 616-624. Go to original source... Go to PubMed...
    14. Benedix F, Westphal S, Patschke E, et al. Weight Loss and Changes in Salivary Ghrelin and Adiponectin: Comparison Between Sleeve Gastrectomy and Roux‑en‑Y Gastric Bypass and Gastric Banding. Obes Surg, 2011; 21: 616-624. Go to original source... Go to PubMed...
    15. Singla V, Aggarwal S, Singh B, et al. Outcomes in super obese patients undergoing one anastomosis gastric bypass or laparoscopic sleeve gastrectomy. Obes Surg. 2019; 29(4): 1242-1247. Go to original source... Go to PubMed...
    16. Sinclair P, Docherty N, et al. Metabolic Effects of Bariatric Surgery. Clin Chem. 2018; 64(1): 72-81. DOI: 10.1373/clinchem.2017.27233. Go to original source...
    17. Bradnova O, Kyrou I, Hainer V, et al. Laparoscopic greater curvature plication in morbidly obese women with type 2 diabetes: effects on glucose homeostasis, postprandial triglyceridemia and selected gut hormones Obes Surg 2014; 24(5): 718-726. doi: 10.1007/s11695-013-1143-4. Go to original source... Go to PubMed...
    18. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004; 351(26): 2683-2693. Go to original source... Go to PubMed...
    19. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357(8): 741-752. Go to original source... Go to PubMed...
    20. Nocca D, Guillaume F, Noel P, et al. Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological tratment of type 2 diabetes mellitus in severe or morbidly obese patiens. Results of a multicenter prospective study at 1 year. Obes Surg 2011; 21: 738-743. Go to original source... Go to PubMed...
    21. De Luca M, Angrisani L,Himpens J. Indications for Surgery for Obesity andWeight‑Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg, 2016: 1659-1696. DOI 10.1007/s11695-016-2271-4. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.